NEUROLOGIE PRO PRAXI / Neurol. praxi. 2024;25(4):256-262 / www.neurologiepropraxi.cz 262 HLAVNÍ TÉMA Praktická diagnostika nádorov CNS podľa WHO klasifikácie 2021: všeobecné zmeny a diagnostika difúznych gliómov 9. Ellison DW, Aldape KD, Capper D, et al. cIMPACT‑NOW upda‑ te 7: advancing the molecular classification of ependymal tu‑ mors. Brain Pathol. 2020;30(5):863–866. doi: 10.1111/bpa.12866. 10. Ellison DW, Hawkins C, Jones DTW, et al. cIMPACT‑NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAFV600E mutation. Acta Neuropathol. 2019;137(4):683–687. doi: 10.1007/s00401-019-01987-0. 11. Jaunmuktane Z, Capper D, Jones DTW, et al. Methylation array profiling of adult brain tumours: diagnostic outcomes in a large, single centre. Acta Neuropathol Commun. 2019;7(1):24. doi: 10.1186/s40478-019-0668-8. 12. Karimi S, Zuccato JA, Mamatjan Y, et al. The central nervous system tumor methylation classifier changes neuro‑oncology practice for challenging brain tumor diagnoses and directly im‑ pacts patient care. Clin Epigenetics. 2019;11(1):185. doi: 10.1186/ s13148-019-0766-2. 13. Keck MK, Sill M, Wittmann A, et al. Amplification of the PLAG ‑family genes‑PLAGL1 and PLAGL2-is a key feature of the no‑ vel tumor type CNS embryonal tumor with PLAGL amplifica‑ tion. Acta Neuropathol. 2023;145(1):49-69. doi: 10.1007/s00401022-02516-2. 14. Louis DN, Giannini C, Capper D, et al. cIMPACT‑NOW up‑ date 2: diagnostic clarifications for diffuse midline glioma, H3 K27M‑mutant and diffuse astrocytoma/anaplastic astrocyto‑ ma, IDH‑mutant. Acta Neuropathol. 2018;135(4):639-642. doi: 10.1007/s00401-018-1826-y. 15. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK. World He‑ alth Organization Classification of Tumours of the Central Ner‑ vous System. 4th ed., updated ed. Lyon: International Agency for Research on Cancer. 2016. 408 s. ISBN 978-92-832-4492-9. 16. Louis DN, Perry A, Wesseling P, Brat DJ, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a sum‑ mary. Neuro Oncol. 2021;23(8):1231-1251. doi: 10.1093/neuonc/ noab106. 17. Louis DN, Wesseling P, Aldape K, et al. cIMPACT‑NOW up‑ date 6: new entity and diagnostic principle recommenda‑ tions of the cIMPACTUtrecht meeting on future CNS tumor classification and grading. Brain Pathol. 2020;30(4):844–856. doi: 10.1111/bpa.12832. 18. Louis DN, Wesseling P, Paulus W, et al. cIMPACT‑NOW upda‑ te 1: Not Otherwise Specified (NOS) and Not Elsewhere Classi‑ fied (NEC). Acta Neuropathol. 2018;135(3):481–484. doi: 10.1007/ s00401-018-1808-0. 19. Muench A, Teichmann D, Spille D, et al. A Novel Type of IDH‑wildtype Glioma Characterized by Gliomatosis Cerebri ‑like Growth Pattern, TERT Promoter Mutation, and Distinct Epigenetic Profile. Am J Surg Pathol. 2023;47(12):1364-1375. doi: 10.1097/PAS.0000000000002118. 20. Pratt D, Abdullaev Z, Papanicolau‑Sengos A, Ketchum C, et al. High‑grade glioma with pleomorphic and pseudo‑ papillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations and re‑ current monosomy 13. Acta Neuropathol. 2022;143(3):403-414. doi: 10.1007/s00401-022-02404-9. 21. Priesterbach‑Ackley LP, Boldt HB, Petersen JK, et al. Bra‑ in tumour diagnostics using a DNA methylation‑based classifier as a diagnostic support tool. Neuropathol Appl Neurobiol. 2020;46(5):478-492. doi: 10.1111/nan.12610. 22. Schepke E, Löfgren M, Pietsch T, et al. DNA methylation profiling improves routine diagnosis of paediatric central nervous system tumours: A prospective population‑based study. Neuropathol Appl Neurobiol. 2022;48(6):e12838. doi: 10.1111/nan.12838. 23. Sievers P, Sill M, Schrimpf D, et al. A subset of pediatric ‑type thalamic gliomas share a distinct DNA methyla‑ tion profile, H3K27me3 loss and frequent alteration of EGFR. Neuro Oncol. 2021;23(1):34-43. doi: 10.1093/neu‑ onc/noaa251. 24. Tauziède‑Espariat A, Siegfried A, Nicaise Y, et al. PLAG1 fusions extend the spectrum of PLAG(L)-altered CNS tu‑ mors. Acta Neuropathol. 2023;146(6):841-844. doi: 10.1007/ s00401-023-02643-4. 25. Tauziède‑Espariat A, Volodia‑Dangouloff‑Ros, Figarella ‑Branger D, et al. Clinicopathological and molecular charac‑ terization of three cases classified by DNA‑methylation pro‑ filing as „Glioneuronal Tumors, NOS, Subtype A“. Acta Neuropathol. 2022;144(6):1179-1183. 26. WHO Classification of Tumours Editorial Board. World He‑ alth Organization Classification of Tumours of the Central Ner‑ vous System. 5th ed. Lyon: 1. International Agency for Rese‑ arch on Cancer. 2021. 568 s. ISBN 9789283245087. ODBORNÝ GARANT: doc. RNDr. MUDr. Pavel Ješina, Ph.D. POŘADATEL: Společnost SOLEN, s. r. o., ve spolupráci s Klinikou pediatrie a dědičných poruch metabolismu 1. LF UK a VFN v Praze ZLATÝ PARTNER POČET KREDITŮ 2 Registrace ZDARMA TERMÍN květen 2024 až duben 2025 dostupný na online.solen.cz ON LINE KURZ OBSAH KURZU Úvod do lyzosomálních střádavých onemocnění doc. RNDr. MUDr. Pavel Ješina, Ph.D. Niemann-Pickova choroba typu B – nové léčitelné onemocnění doc. RNDr. MUDr. Pavel Ješina, Ph.D. Gaucherova nemoc – snadno diagnostikovatelné onemocnění MUDr. Stella Reichmannová, Ph.D. Pompeho nemoc – jak odhalit typické i méně typické případy MUDr. Lívie Mensová Diskuze Našli jsme vzácného pacienta – hledejme dál
RkJQdWJsaXNoZXIy NDA4Mjc=